To investigate the potential mechanisms underlying the role of SART3 in HCC, we identified 1063 DEGs (|log2FoldChange| >1.5, p < 0.05) between samples with high and low SART3 expression in the TCGA LIHC cohort (Figure 7A). This evidence concerns the gene SART3 and hepatocellular carcinoma.